Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 1
1979 2
1982 2
1984 1
1985 4
1986 1
1987 4
1988 4
1989 7
1990 10
1991 10
1992 20
1993 19
1994 15
1995 10
1996 21
1997 21
1998 22
1999 17
2000 25
2001 26
2002 30
2003 18
2004 35
2005 39
2006 36
2007 45
2008 45
2009 38
2010 39
2011 60
2012 51
2013 49
2014 50
2015 56
2016 47
2017 47
2018 66
2019 70
2020 70
2021 85
2022 70
2023 70
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

1,266 results

Results by year

Filters applied: . Clear all
The following terms were not found in PubMed: microcephaly-seizures-cortical, blindness-developmental
Page 1
The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.
Atri A. Atri A. Med Clin North Am. 2019 Mar;103(2):263-293. doi: 10.1016/j.mcna.2018.10.009. Med Clin North Am. 2019. PMID: 30704681 Free article. Review.
Alzheimer's disease (AD) care requires timely diagnosis and multidisciplinary management. ...When combined, pharmacologic and nonpharmacologic therapies mitigate symptoms and reduce clinical progression and care burden. AD biopathologic processes develop over decade …
Alzheimer's disease (AD) care requires timely diagnosis and multidisciplinary management. ...When combined, pharmacologic and nonphar …
PCDH19-Related Epilepsy Syndrome: A Comprehensive Clinical Review.
Samanta D. Samanta D. Pediatr Neurol. 2020 Apr;105:3-9. doi: 10.1016/j.pediatrneurol.2019.10.009. Epub 2019 Nov 30. Pediatr Neurol. 2020. PMID: 32057594 Review.
PCDH19-related epilepsy is a distinct childhood-onset epilepsy syndrome characterized by brief clusters of febrile and afebrile seizures with onset primarily before the age of three years, cognitive impairment, autistic traits, and behavioral abnormalities. ...More rigorou …
PCDH19-related epilepsy is a distinct childhood-onset epilepsy syndrome characterized by brief clusters of febrile and afebrile seizu …
Wolfram Syndrome: Diagnosis, Management, and Treatment.
Urano F. Urano F. Curr Diab Rep. 2016 Jan;16(1):6. doi: 10.1007/s11892-015-0702-6. Curr Diab Rep. 2016. PMID: 26742931 Free PMC article. Review.
Although there are currently no effective treatments that can delay or reverse the progression of Wolfram syndrome, the use of careful clinical monitoring and supportive care can help relieve the suffering of patients and improve their quality of life. The pr …
Although there are currently no effective treatments that can delay or reverse the progression of Wolfram syndrome, the …
New Approaches to Myelodysplastic Syndrome Treatment.
Bazinet A, Bravo GM. Bazinet A, et al. Curr Treat Options Oncol. 2022 May;23(5):668-687. doi: 10.1007/s11864-022-00965-1. Epub 2022 Mar 23. Curr Treat Options Oncol. 2022. PMID: 35320468 Review.
The treatment of myelodysplastic syndromes (MDS) begins with risk stratification using a validated tool such as the International Prognostic Scoring System (IPSS) or its revised version (IPSS-R). ...Although treatment objectives in lower-risk MDS (LR-MDS) have traditionall …
The treatment of myelodysplastic syndromes (MDS) begins with risk stratification using a validated tool such as the International Pro …
Deciphering the concepts behind "Epileptic encephalopathy" and "Developmental and epileptic encephalopathy".
Scheffer IE, Liao J. Scheffer IE, et al. Eur J Paediatr Neurol. 2020 Jan;24:11-14. doi: 10.1016/j.ejpn.2019.12.023. Epub 2019 Dec 31. Eur J Paediatr Neurol. 2020. PMID: 31926847 Review.
The term 'developmental' was introduced as there are multiple facets leading to developmental impairment in affected individuals. The underlying genetic cause often results in developmental delay in its own right, with the epileptic encephalopathy further adversely affecti …
The term 'developmental' was introduced as there are multiple facets leading to developmental impairment in affected individuals. The underl …
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
Carroll A, Dyck PJ, de Carvalho M, Kennerson M, Reilly MM, Kiernan MC, Vucic S. Carroll A, et al. J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):668-678. doi: 10.1136/jnnp-2021-327909. Epub 2022 Mar 7. J Neurol Neurosurg Psychiatry. 2022. PMID: 35256455 Free PMC article. Review.
TTR protein stabilisers diflunisal and tafamidis can delay the progression of the disease, if treated early in the course. ...This review highlights the key advances in the diagnostic techniques, current and emerging management strategies, and biomarker devel …
TTR protein stabilisers diflunisal and tafamidis can delay the progression of the disease, if treated early in the cour …
Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives.
Pedrosa AL, Bitencourt L, Paranhos RM, Leitáo CA, Ferreira GC, Simões E Silva AC. Pedrosa AL, et al. Curr Med Chem. 2021;28(27):5602-5624. doi: 10.2174/0929867328666210108113500. Curr Med Chem. 2021. PMID: 33423643 Review.
BACKGROUND: Alport syndrome (AS) is a disease caused by mutations in COL4A3, COL4A4 or COL4A5, the genes that encode distinct chains of type IV collagen. ...There are no formally approved treatments for AS, even though therapeutic options have been described to d …
BACKGROUND: Alport syndrome (AS) is a disease caused by mutations in COL4A3, COL4A4 or COL4A5, the genes that encode distinct …
Natural history and mechanisms of COPD.
Lange P, Ahmed E, Lahmar ZM, Martinez FJ, Bourdin A. Lange P, et al. Respirology. 2021 Apr;26(4):298-321. doi: 10.1111/resp.14007. Epub 2021 Jan 28. Respirology. 2021. PMID: 33506971 Free article. Review.
It is now accepted that individuals presenting with different COPD phenotypes may experience varying natural history of their disease. This includes its inception, early stages and progression to established disease. ...Regardless of the FEV(1) trajectory, co …
It is now accepted that individuals presenting with different COPD phenotypes may experience varying natural history of their disease …
[Update on leptospirosis].
Le Turnier P, Epelboin L. Le Turnier P, et al. Rev Med Interne. 2019 May;40(5):306-312. doi: 10.1016/j.revmed.2018.12.003. Epub 2018 Dec 24. Rev Med Interne. 2019. PMID: 30591382 Review. French.
The clinical symptoms, particularly in the initial phase, are not specific and can limit to a flu-like syndrome or "dengue-like" making diagnosis often difficult. It is then necessary to look carefully for clinical (muscle pain, cough, conjunctival involvement, jaundice) a …
The clinical symptoms, particularly in the initial phase, are not specific and can limit to a flu-like syndrome or "dengue-like" maki …
New understanding of the pathogenesis and treatment of stroke-related sarcopenia.
Li W, Yue T, Liu Y. Li W, et al. Biomed Pharmacother. 2020 Nov;131:110721. doi: 10.1016/j.biopha.2020.110721. Epub 2020 Sep 10. Biomed Pharmacother. 2020. PMID: 32920517 Free article. Review.
Sarcopenia is a syndrome characterized by progressive systemic muscle loss and decreased function. ...At present, there is still no particularly effective way to stop its progress,however, the combination of rehabilitation exercise, nutrition supply and drugs …
Sarcopenia is a syndrome characterized by progressive systemic muscle loss and decreased function. ...At present, there is sti …
1,266 results